By 2050, the global community as per World Health Organization (WHO) estimates will face a whopping 77 per cent increase in cancer cases.

A report by the WHO's cancer agency, the International Agency for Research on Cancer (IARC), predicts that in a little more than two decades, we will see more than 35 million new cancer cases. This is a 77 per cent increase from the estimated 20 million cases recorded in 2022.

Also read |&nbsp;<a href="https://www.wionews.com/science/japans-moon-lander-goes-dormant-once-again-amazing-final-image-of-lunar-surface-see-it-here-686216">Japan's moon lander clicks final image before going dormant once again</a>

However, as per&nbsp;Dr Freddie Bray, Head of the Cancer Surveillance Branch at IARC, the impact of the increase "will not be felt evenly across countries."

<h2>Report findings</h2>

In the report released ahead of World Cancer Day, which is observed on February 4th, the IARC predicted a massive increase in the global cancer burden.

"The rapidly growing global cancer burden reflects both population ageing and growth, as well as changes to people’s exposure to risk factors, several of which are associated with socioeconomic development," said the WHO in its press release.

It identified tobacco, alcohol, and obesity as the key factors driving the increasing incidence of cancer. Air Pollution was mentioned as a key driver of environmental risk factors.

Watch |&nbsp;Cancer experts unveil groundbreaking discovery, eliminates need for invasive surgeries

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/cancer-experts-unveil-groundbreaking-discovery-eliminates-need-for-invasive-surgeries-wion-674613/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>
</div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

Furthermore, it predicts that high HDI (Human Development Index) countries will experience the greatest absolute increase in incidence of cancer cases, with an additional 4.8 million new cases predicted in 2050 compared with 2022 estimates.

In a statement, the Head of the Cancer Surveillance Branch at IARC, said: "The impact of this increase will not be felt evenly across countries of different HDI levels. Those who have the fewest resources to manage their cancer burdens will bear the brunt of the global cancer burden."

Also read |&nbsp;<a href="https://www.wionews.com/science/massive-clue-found-solving-why-80-pc-of-autoimmune-patients-are-women-686120">Massive clue found solving why 80 pc of autoimmune patients are women</a>

As per WHO, global estimates reveal "striking inequalities" in human development.

Dr Isabelle Soerjomataram, Deputy Head of the Cancer Surveillance Branch at IARC explains,&nbsp;"Women in lower HDI countries are 50 &nbsp;per cent less likely to be diagnosed with breast cancer than women in high HDI countries, yet they are at a much higher risk of dying of the disease due to late diagnosis and inadequate access to quality treatment."

(With inputs from agencies)

By 2050, the global community as per World Health Organization (WHO) estimates will face a whopping 77 per cent increase in cancer cases. A report by the WHO's cancer agency, the International Agency for Research on Cancer (IARC), predicts that in a little more than two decades, we will see more than 35 million new cancer cases.

By 2050, the global community as per World Health Organization (WHO) estimates will face a whopping 77 per cent increase in cancer cases. A report by the WHO's cancer agency, the International Agency for Research on Cancer (IARC), predicts that in a little more than two decades, we will see more than 35 million new cancer cases. This is a 77 per cent increase from the estimated 20 million cases recorded in 2022. Also read | Japan's moon lander clicks final image before going dormant once again However, as per Dr Freddie Bray, Head of the Cancer Surveillance Branch at IARC, the impact of the increase "will not be felt evenly across countries." Report findings In the report released ahead of World Cancer Day, which is observed on February 4th, the IARC predicted a massive increase in the global cancer burden. "The rapidly growing global cancer burden reflects both population ageing and growth, as well as changes to people’s exposure to risk factors, several of which are associated with socioeconomic development," said the WHO in its press release. It identified tobacco, alcohol, and obesity as the key factors driving the increasing incidence of cancer. Air Pollution was mentioned as a key driver of environmental risk factors. Watch | Cancer experts unveil groundbreaking discovery, eliminates need for invasive surgeries × Furthermore, it predicts that high HDI (Human Development Index) countries will experience the greatest absolute increase in incidence of cancer cases, with an additional 4.8 million new cases predicted in 2050 compared with 2022 estimates. In a statement, the Head of the Cancer Surveillance Branch at IARC, said: "The impact of this increase will not be felt evenly across countries of different HDI levels. Those who have the fewest resources to manage their cancer burdens will bear the brunt of the global cancer burden." Also read | Massive clue found solving why 80 pc of autoimmune patients are women As per WHO, global estimates reveal "striking inequalities" in human development. Dr Isabelle Soerjomataram, Deputy Head of the Cancer Surveillance Branch at IARC explains, "Women in lower HDI countries are 50 per cent less likely to be diagnosed with breast cancer than women in high HDI countries, yet they are at a much higher risk of dying of the disease due to late diagnosis and inadequate access to quality treatment." (With inputs from agencies)

By 2050, the world will see a whopping 77% increase in cancer cases, predicts WHO report

Sheila Bush was lounging in the recliner at her St. Louis-area home last winter when an ad from a law firm flashed up on her television screen, urging viewers to call a toll-free number if they or anyone they knew had used hair relaxers and been diagnosed with uterine cancer.

The fourth time she saw the ad, Bush picked up the phone, she said.

The television advertisements Bush viewed were part of a nationwide effort by plaintiffs’ law firms to sign up Black women to file lawsuits alleging at least a dozen cosmetic companies, including L’Oreal and Revlon, sold hair relaxers containing chemicals that increased the risk of developing uterine cancer – and failed to warn customers.

The recruitment campaign launched last October, days after a US&nbsp;National Institutes of Health (NIH) study found an association, though not a causal link, between frequent use of chemical hair relaxers and uterine cancer.

Some of the ads show Black women applying hair products before cutting to a summary of the NIH study’s findings.

L’Oreal and Revlon told Reuters their products are subject to rigorous safety reviews and that they do not believe current science supports the allegations in the lawsuits. The other companies declined to comment or didn't respond to requests. L’Oreal and Revlon declined Reuters’ requests to interview their lawyers.

Also read |&nbsp;<a href="https://www.wionews.com/science/moderate-consumption-of-tea-coffee-linked-to-decreased-risks-of-cognitive-disorders-study-655274">Moderate consumption of tea, coffee linked to decreased risks of cognitive disorders: Study</a>

So far, about 6,000 cases have been filed– more than 5,700 of them since mid-August, according to the US&nbsp;Judicial Panel on Multidistrict Litigation. But the cases face hurdles: The NIH study showed only correlation, not causation. Plaintiffs are suing multiple companies, but many women lack receipts and may struggle to provide evidence that they used specific products.

The success of the legal claims will hinge on demonstrating the companies were negligent and failed to warn customers about allegedly toxic products. Marketing hair relaxers to Black women isn’t in and of itself illegal.

Ben Crump, who represented the family of George Floyd, the Black man murdered by a Minneapolis police officer in 2020, and another lawyer, Diandra “Fu” Debrosse Zimmerman, filed the first hair relaxer lawsuit on behalf of a Missouri woman, Jenny Mitchell, in October last year. Crump has sought to cast the cases as “essentially civil rights issues.”

Also read |&nbsp;<a href="https://www.wionews.com/science/ageing-doesnt-hinder-our-ability-to-use-hands-and-fingers-with-precision-study-655325">Ageing doesn’t hinder our ability to use hands and fingers with precision: Study</a>

For Black women, “it’s projected on them that they have to live up to some kind of European standard of beauty,” Crump, who represents plaintiffs in high-profile racial discrimination cases and is a regular on cable news, said in an interview.

A master complaint filed in a proceeding consolidating the lawsuits alleges the companies took advantage of “centuries of racial discrimination and cultural coercion which emphasized—both socially and professionally—the necessity of maintaining straight hair.”

A cosmetologist who worked in salons frequented by white customers, Bush, 69, said she had used hair relaxers every six weeks for most of her life. She was diagnosed with uterine cancer when she was in her late 50s.

In August, she joined the litigation, consolidated in a Chicago federal court as part of a multidistrict litigation proceeding (MDL), a procedure designed to more efficiently manage lawsuits filed in multiple jurisdictions.

She hopes her lawsuit can help establish whether hair relaxers cause cancer. “I want to know for sure,” she said.

Uterine cancer is the most common form of reproductive system cancer and rising in the US, especially among Black women, according to the NIH.

The NIH study of 34,000 women found that those who reported using hair straightening products more than four times in the previous year were more than twice as likely to develop uterine cancer as those who did not. Black women have used the products more frequently than others, the study found.

Hair relaxers have been found to include phthalates, parabens, cyclosiloxanes and metals, and may release formaldehyde when heated, Alexandra White, head of the National Institute of Environmental Health Sciences’ Environment and Cancer Epidemiology group and lead author of the October study, said in a statement. She declined multiple interview requests through a spokesperson.

Formaldehyde is a known carcinogen and has been linked to nasopharyngeal cancer and leukemia, according to the World Health Organization. The NIH study said phthalates and the other chemicals are suspected endocrine disruptors, which can interfere with the body’s hormones and are suspected of contributing to cancer risk.

L’Oreal and Revlon noted that the NIH study did not draw definitive conclusions about a causal link between hair relaxers and uterine cancer and that its authors said more research is warranted. “We do not believe the science supports a link between chemical hair straighteners or relaxers and cancer,” Revlon said.

The companies named in the litigation asked the presiding judge in July to dismiss the lawsuits, noting that the study was the first to raise a possible association between hair straightening products and uterine cancer, undermining plaintiffs’ argument that the companies knew or should have known of any risks related to the products.

The companies also noted that the NIH study consisted of sisters of women previously diagnosed with breast cancer “who therefore may have a genetic predisposition.” Lead author White said in a statement that there is currently no strong evidence linking family history of breast cancer to increased risk of uterine cancer.

The plaintiffs “rely entirely on vague allegations that the products, generally, contain ‘toxic chemicals,’” the companies’ defense lawyers at Paul, Weiss, Rifkind &amp; Garrison, Arnold &amp; Porter Kaye Scholer and other firms said in a court filing.

The brands named in the lawsuit are intended for use at home and include L’Oreal’s SoftSheen Carson’s Dark &amp; Lovely, Revlon, Dabur’s Namaste ORS Olive Oil, Godrej’s Strength of Nature’s Just for Me, and Sally Beauty Holdings’ Silk Elements.

In an August court filing, all the companies said that plaintiffs in many instances failed to identify specific products they used or how individual products harmed them.

Should plaintiffs survive the companies’ request to dismiss the cases, they will still likely face a request from defendants for the judge to grant them summary judgment, or a ruling in their favor without the cases going to trial.

And if the cases do go forward, the companies’ lawyers could attempt to exclude experts or evidence plaintiffs’ lawyers intend to introduce at trial.

Future trials testing both sides’ cases would determine whether the companies face any liability and how much they must pay in a settlement, should one occur.

“These cases are no guarantee of success,” said Rene Rocha, a Morgan &amp; Morgan lawyer representing hair relaxer plaintiffs, adding he believes the cases will survive the companies’ initial legal challenges “because the science is clear.”

At this stage, plaintiffs can advance their case without proving the products caused cancer, said Jennifer Hoekstra, a lawyer representing Bush. The study from a reputable government institution such as the NIH is likely enough to get cases before a jury, she said.

Framing the litigation as a civil rights issue could resonate with jurors beyond arguments over complex product liability claims, said Adam Zimmerman, a professor at the University of Southern California Gould School of Law who studies mass tort litigation.

“Mass torts don’t happen in a vacuum,” Zimmerman said.

L’Oreal said that it is committed to offering the best products “for all skin and hair types, all genders, all identities, all cultures, all ages” and that its hair relaxers have a “rich heritage and history” originating with Black inventors and entrepreneurs.

Since November last year, plaintiffs’ lawyers have spent about $8 million airing more than 40,000 television ads across the US, with much of it concentrated in Baltimore, Houston and Washington DC, according to an analysis of marketing data compiled for Reuters by X Ante, a firm that tracks mass tort advertising for large companies, law firms and investment analysts.

Reuters spoke with six legal experts uninvolved in the litigation who expect the number of hair relaxer lawsuits to grow. The judge overseeing the litigation over the summer approved a so-called short-form complaint that makes it relatively easy for plaintiffs to file lawsuits.

Lawyers seeking hair relaxer plaintiffs have posted on social-media platforms and attended community events. In June, Tiseme Zegeye, a partner at Lieff Cabraser, a large plaintiffs’ law firm, visited a Southern California health expo where she stood at a booth with a sign reading, “Black Health is a Human Right,” according to the firm’s website.

In 2019, law firms seeking to sue manufacturer 3M over allegedly defective military earplugs spent $18 million on television advertising, according to X Ante. 3M, which denied the allegations, faced more than 250,000 legal actions before reaching a settlement.

When Ariana Hester, an event manager in San Diego, decided to stop using hair relaxers in her 20s, her mother Patrice warned that wearing natural hair would attract unwanted attention.

“She never wanted us to do anything to make us stand out or be a target,” said Ariana, now 35.

Photos show Patrice wore a pageboy cut when she worked as a journalist in Baltimore in the 1970s, and a shoulder-length bob in the early 2000s when she embarked on a career as a realtor in San Diego. She continued to straighten her hair after she was diagnosed with uterine cancer in late 2021, although her three daughters begged her to stop applying the chemicals while she was fighting cancer, they said.

When Patrice died last November, her hair was freshly relaxed, Ariana said. She was 68 years old.

The Hester sisters have spoken to a law firm and said they intend to join the litigation against the companies that made the hair relaxers their mother applied including Godrej’s African Pride and Dabur International’s ORS, boxes of which still sit in the bathroom of the home she shared with Ariana and another daughter, Nakisha.

Sheila Bush was lounging in the recliner at her St. Louis-area home last winter when an ad from a law firm flashed up on her television screen, urging viewers to call a toll-free number if they or anyone they knew had used hair relaxers and been diagnosed with uterine cancer.

Sheila Bush was lounging in the recliner at her St. Louis-area home last winter when an ad from a law firm flashed up on her television screen, urging viewers to call a toll-free number if they or anyone they knew had used hair relaxers and been diagnosed with uterine cancer. The fourth time she saw the ad, Bush picked up the phone, she said. The television advertisements Bush viewed were part of a nationwide effort by plaintiffs’ law firms to sign up Black women to file lawsuits alleging at least a dozen cosmetic companies, including L’Oreal and Revlon, sold hair relaxers containing chemicals that increased the risk of developing uterine cancer – and failed to warn customers. The recruitment campaign launched last October, days after a US National Institutes of Health (NIH) study found an association, though not a causal link, between frequent use of chemical hair relaxers and uterine cancer. Some of the ads show Black women applying hair products before cutting to a summary of the NIH study’s findings. L’Oreal and Revlon told Reuters their products are subject to rigorous safety reviews and that they do not believe current science supports the allegations in the lawsuits. The other companies declined to comment or didn't respond to requests. L’Oreal and Revlon declined Reuters’ requests to interview their lawyers. Also read | Moderate consumption of tea, coffee linked to decreased risks of cognitive disorders: Study So far, about 6,000 cases have been filed– more than 5,700 of them since mid-August, according to the US Judicial Panel on Multidistrict Litigation. But the cases face hurdles: The NIH study showed only correlation, not causation. Plaintiffs are suing multiple companies, but many women lack receipts and may struggle to provide evidence that they used specific products. The success of the legal claims will hinge on demonstrating the companies were negligent and failed to warn customers about allegedly toxic products. Marketing hair relaxers to Black women isn’t in and of itself illegal. Ben Crump, who represented the family of George Floyd, the Black man murdered by a Minneapolis police officer in 2020, and another lawyer, Diandra “Fu” Debrosse Zimmerman, filed the first hair relaxer lawsuit on behalf of a Missouri woman, Jenny Mitchell, in October last year. Crump has sought to cast the cases as “essentially civil rights issues.” Also read | Ageing doesn’t hinder our ability to use hands and fingers with precision: Study For Black women, “it’s projected on them that they have to live up to some kind of European standard of beauty,” Crump, who represents plaintiffs in high-profile racial discrimination cases and is a regular on cable news, said in an interview. A master complaint filed in a proceeding consolidating the lawsuits alleges the companies took advantage of “centuries of racial discrimination and cultural coercion which emphasized—both socially and professionally—the necessity of maintaining straight hair.” A cosmetologist who worked in salons frequented by white customers, Bush, 69, said she had used hair relaxers every six weeks for most of her life. She was diagnosed with uterine cancer when she was in her late 50s. In August, she joined the litigation, consolidated in a Chicago federal court as part of a multidistrict litigation proceeding (MDL), a procedure designed to more efficiently manage lawsuits filed in multiple jurisdictions. She hopes her lawsuit can help establish whether hair relaxers cause cancer. “I want to know for sure,” she said. Uterine cancer is the most common form of reproductive system cancer and rising in the US, especially among Black women, according to the NIH. The NIH study of 34,000 women found that those who reported using hair straightening products more than four times in the previous year were more than twice as likely to develop uterine cancer as those who did not. Black women have used the products more frequently than others, the study found. Hair relaxers have been found to include phthalates, parabens, cyclosiloxanes and metals, and may release formaldehyde when heated, Alexandra White, head of the National Institute of Environmental Health Sciences’ Environment and Cancer Epidemiology group and lead author of the October study, said in a statement. She declined multiple interview requests through a spokesperson. Formaldehyde is a known carcinogen and has been linked to nasopharyngeal cancer and leukemia, according to the World Health Organization. The NIH study said phthalates and the other chemicals are suspected endocrine disruptors, which can interfere with the body’s hormones and are suspected of contributing to cancer risk. L’Oreal and Revlon noted that the NIH study did not draw definitive conclusions about a causal link between hair relaxers and uterine cancer and that its authors said more research is warranted. “We do not believe the science supports a link between chemical hair straighteners or relaxers and cancer,” Revlon said. The companies named in the litigation asked the presiding judge in July to dismiss the lawsuits, noting that the study was the first to raise a possible association between hair straightening products and uterine cancer, undermining plaintiffs’ argument that the companies knew or should have known of any risks related to the products. The companies also noted that the NIH study consisted of sisters of women previously diagnosed with breast cancer “who therefore may have a genetic predisposition.” Lead author White said in a statement that there is currently no strong evidence linking family history of breast cancer to increased risk of uterine cancer. The plaintiffs “rely entirely on vague allegations that the products, generally, contain ‘toxic chemicals,’” the companies’ defense lawyers at Paul, Weiss, Rifkind & Garrison, Arnold & Porter Kaye Scholer and other firms said in a court filing. The brands named in the lawsuit are intended for use at home and include L’Oreal’s SoftSheen Carson’s Dark & Lovely, Revlon, Dabur’s Namaste ORS Olive Oil, Godrej’s Strength of Nature’s Just for Me, and Sally Beauty Holdings’ Silk Elements. In an August court filing, all the companies said that plaintiffs in many instances failed to identify specific products they used or how individual products harmed them. Should plaintiffs survive the companies’ request to dismiss the cases, they will still likely face a request from defendants for the judge to grant them summary judgment, or a ruling in their favor without the cases going to trial. And if the cases do go forward, the companies’ lawyers could attempt to exclude experts or evidence plaintiffs’ lawyers intend to introduce at trial. Future trials testing both sides’ cases would determine whether the companies face any liability and how much they must pay in a settlement, should one occur. “These cases are no guarantee of success,” said Rene Rocha, a Morgan & Morgan lawyer representing hair relaxer plaintiffs, adding he believes the cases will survive the companies’ initial legal challenges “because the science is clear.” At this stage, plaintiffs can advance their case without proving the products caused cancer, said Jennifer Hoekstra, a lawyer representing Bush. The study from a reputable government institution such as the NIH is likely enough to get cases before a jury, she said. Framing the litigation as a civil rights issue could resonate with jurors beyond arguments over complex product liability claims, said Adam Zimmerman, a professor at the University of Southern California Gould School of Law who studies mass tort litigation. “Mass torts don’t happen in a vacuum,” Zimmerman said. L’Oreal said that it is committed to offering the best products “for all skin and hair types, all genders, all identities, all cultures, all ages” and that its hair relaxers have a “rich heritage and history” originating with Black inventors and entrepreneurs. Since November last year, plaintiffs’ lawyers have spent about $8 million airing more than 40,000 television ads across the US, with much of it concentrated in Baltimore, Houston and Washington DC, according to an analysis of marketing data compiled for Reuters by X Ante, a firm that tracks mass tort advertising for large companies, law firms and investment analysts. Reuters spoke with six legal experts uninvolved in the litigation who expect the number of hair relaxer lawsuits to grow. The judge overseeing the litigation over the summer approved a so-called short-form complaint that makes it relatively easy for plaintiffs to file lawsuits. Lawyers seeking hair relaxer plaintiffs have posted on social-media platforms and attended community events. In June, Tiseme Zegeye, a partner at Lieff Cabraser, a large plaintiffs’ law firm, visited a Southern California health expo where she stood at a booth with a sign reading, “Black Health is a Human Right,” according to the firm’s website. In 2019, law firms seeking to sue manufacturer 3M over allegedly defective military earplugs spent $18 million on television advertising, according to X Ante. 3M, which denied the allegations, faced more than 250,000 legal actions before reaching a settlement. When Ariana Hester, an event manager in San Diego, decided to stop using hair relaxers in her 20s, her mother Patrice warned that wearing natural hair would attract unwanted attention. “She never wanted us to do anything to make us stand out or be a target,” said Ariana, now 35. Photos show Patrice wore a pageboy cut when she worked as a journalist in Baltimore in the 1970s, and a shoulder-length bob in the early 2000s when she embarked on a career as a realtor in San Diego. She continued to straighten her hair after she was diagnosed with uterine cancer in late 2021, although her three daughters begged her to stop applying the chemicals while she was fighting cancer, they said. When Patrice died last November, her hair was freshly relaxed, Ariana said. She was 68 years old. The Hester sisters have spoken to a law firm and said they intend to join the litigation against the companies that made the hair relaxers their mother applied including Godrej’s African Pride and Dabur International’s ORS, boxes of which still sit in the bathroom of the home she shared with Ariana and another daughter, Nakisha.

Black women say hair relaxers gave them cancer: Report

The number of people diagnosed with cancer under the age of 50 has increased globally over the span of last 30 years but the reason behind it is not yet clear, revealed a new study on Wednesday (September 6).

As per a study published in the journal BMJ Oncology, the cases of cancer among people aged between 14 to 49 years ascended by nearly 80 per cent, from 1.82 million to 3.26 million, between 1990 to 2019.

Though some experts warned that the probable reason behind the increase in number was also linked to the growth in population, previous studies have highlighted that the disease is becoming more common among people under 50 years of age.

Poor diet, smoking and alcohol have been named as major factors behind this by the international team of researchers behind the new study.

But "the increasing trend of early-onset cancer burden is still unclear," they added.

A little over one million people under the age of 50 lost their lives to cancer in the year 2019, which went up by 28 per cent from the year 1990, said the study.

<h2>Deadliest cancers</h2>

The deadliest cancers that claimed the lives of many included breast, windpipe, lung, bowel and stomach cancers, according to the study.

Breast cancer was the one that was mostly diagnosed over the three decades. But the cancers that rose rapidly were of the nasopharynx, where the back of the nose meets the top of the throat and the prostate. Meanwhile, liver cancer fell by 2.9 per cent a year.

The researchers used data from the 2019 Global Burden of Disease Study, examining the rates of 29 different cancers in 204 countries.

According to the study, the developed countries had a higher rate of under-50s diagnosed with cancer.

Also read: <a href="https://www.wionews.com/science/one-in-three-men-infected-with-genital-hpv-globally-claims-study-632722">One in three men infected with genital HPV globally, claims study</a>

This could suggest that richer countries with better healthcare systems catch cancer earlier, but only a few nations screen for certain cancers in people under 50, the study added.

It said that factors like poor diet, smoking and drinking, genetic factors, physical inactivity and obesity could also contribute to the trend.

Modelling predicted that the number of global cancer cases in those under 50&nbsp;will rise further 31 per cent by 2030, mostly among people aged 40-49.

The experts who weren't involved in the study said that the gradual upsurge in the number of deaths compared to the cases was presumably due to advancements in early detection and treatment.

Dorothy Bennett, a researcher at the University of London, highlighted that the world's population rose by roughly 46 per cent between 1990 and 2019, which could be another reason behind the increasing cases.

Two doctors at Queen's University Belfast, Ashleigh Hamilton and Helen Coleman, said it was "crucial" to work out what was behind the increasing cases.

"Full understanding of the reasons driving the observed trends remains elusive, although lifestyle factors are likely contributing, and novel areas of research such as antibiotic usage, the gut microbiome, outdoor air pollution and early life exposures are being explored," they said in an editorial linked to the study.

(With inputs from agencies) 
&nbsp;

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

You can now write for wionews.com and be a part of the community. Share your stories and opinions with us <a href="https://www.wionews.com/content-contribution-registration-form">here</a>.

The number of people diagnosed with cancer under the age of 50 has increased globally over the span of last 30 years but the reason behind it is not yet clear, revealed a new study on Wednesday (September 6).

The number of people diagnosed with cancer under the age of 50 has increased globally over the span of last 30 years but the reason behind it is not yet clear, revealed a new study on Wednesday (September 6). As per a study published in the journal BMJ Oncology, the cases of cancer among people aged between 14 to 49 years ascended by nearly 80 per cent, from 1.82 million to 3.26 million, between 1990 to 2019. Though some experts warned that the probable reason behind the increase in number was also linked to the growth in population, previous studies have highlighted that the disease is becoming more common among people under 50 years of age. Poor diet, smoking and alcohol have been named as major factors behind this by the international team of researchers behind the new study. But "the increasing trend of early-onset cancer burden is still unclear," they added. A little over one million people under the age of 50 lost their lives to cancer in the year 2019, which went up by 28 per cent from the year 1990, said the study. Deadliest cancers The deadliest cancers that claimed the lives of many included breast, windpipe, lung, bowel and stomach cancers, according to the study. Breast cancer was the one that was mostly diagnosed over the three decades. But the cancers that rose rapidly were of the nasopharynx, where the back of the nose meets the top of the throat and the prostate. Meanwhile, liver cancer fell by 2.9 per cent a year. The researchers used data from the 2019 Global Burden of Disease Study, examining the rates of 29 different cancers in 204 countries. According to the study, the developed countries had a higher rate of under-50s diagnosed with cancer. Also read: One in three men infected with genital HPV globally, claims study This could suggest that richer countries with better healthcare systems catch cancer earlier, but only a few nations screen for certain cancers in people under 50, the study added. It said that factors like poor diet, smoking and drinking, genetic factors, physical inactivity and obesity could also contribute to the trend. Modelling predicted that the number of global cancer cases in those under 50 will rise further 31 per cent by 2030, mostly among people aged 40-49. The experts who weren't involved in the study said that the gradual upsurge in the number of deaths compared to the cases was presumably due to advancements in early detection and treatment. Dorothy Bennett, a researcher at the University of London, highlighted that the world's population rose by roughly 46 per cent between 1990 and 2019, which could be another reason behind the increasing cases. Two doctors at Queen's University Belfast, Ashleigh Hamilton and Helen Coleman, said it was "crucial" to work out what was behind the increasing cases. "Full understanding of the reasons driving the observed trends remains elusive, although lifestyle factors are likely contributing, and novel areas of research such as antibiotic usage, the gut microbiome, outdoor air pollution and early life exposures are being explored," they said in an editorial linked to the study. (With inputs from agencies) WATCH WION LIVE HERE You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here.

Number of people under 50 diagnosed with cancer has surged worldwide, reveals study

Studies show that the rate of early-onset cancer is rising among young people since 1990. At least 13 young people out of 100,000 are suffering from breast cancer. How can youngsters avoid the risks of cancer? Molly Gambhir gets you a report.

Gravitas: 'Global Surge' In Cancer Cases Among Young People

Steve Scalise, the second-ranking Republican in the US House of Representatives, has revealed that he has been diagnosed with a rare form of cancer.&nbsp;

The House Majority leader announced that he has been diagnosed with multiple myeloma, a form of blood cancer.&nbsp;

"I expect to work through this period and intend to return to Washington," said the Louisiana lawmaker who previously survived a mass shooting in 2017.

<h2>Scalise's statement</h2>

In a statement on Tuesday, Scalise said that he had sought medical attention after feeling unwell for a few days.

"After a few days of not feeling like myself this past week, I had some blood work done".

Also read |&nbsp;<a href="https://www.wionews.com/world/air-pollution-a-silent-threat-deadlier-than-smoking-and-alcohol-reveals-new-study-630309">Air pollution: A silent threat deadlier than smoking and alcohol, reveals new study</a>

"The results uncovered some irregularities and after undergoing additional tests, I was diagnosed with Multiple Myeloma, a very treatable blood cancer," he added. 
&nbsp; 
Expressing gratitude for the early detection of the cancer, he said: "I am thankful for my excellent medical team, and with the help of God, support of my family, friends, colleagues, and constituents, I will tackle this with the same strength and energy as I have tackled past challenges."

<h2>Who is Steve Scalise?</h2>

The 57-year-old congressman was elected to the US Congress in 2008. Over the years, he steadily climbed the ranks of Republican leadership.&nbsp;

Currently, he is serving as the right-hand man to House Speaker Kevin McCarthy, and&nbsp;plays a pivotal role in keeping the chamber's conservative majority in line.

Also read |&nbsp;<a href="https://www.wionews.com/world/drink-and-drive-japanese-police-use-unique-approach-to-show-dangers-of-drunk-driving-630330">Drink and drive? Japanese police use unique approach to show dangers of drunk driving</a>

Notably, in 2017, Scalise was one of the five victims of a mass shooting during a congressional baseball practice. He was shot in the hip by a gunman who opened fire on the group, injuring five people.&nbsp;

He underwent a months-long recovery and eventually returned to work.

Colleagues and fellow politicians from the Republican Party offered messages of support to Scalise. Highlighting his remarkable recovery from the earlier shooting as a testament to his resilience, Senator Bill Cassidy of Louisiana said: "The same faith, family support, and internal strength that made Steve such an inspiration to others after he was shot, will bring him through this illness and once more inspire us all."

<h2>Multiple myeloma&nbsp;</h2>

Multiple myeloma is a relatively uncommon form of cancer in the United States. According to the American Cancer Society, approximately 35,730 new cases are expected to be diagnosed this year. This, as per a Forbes report citing the National Cancer Institute, represents merely two per cent of all cancer diagnoses in the country. The disease affects plasma cells, a type of white blood cell that helps our body's immune response.

Steve Scalise, the second-ranking Republican in the US House of Representatives, has revealed that he has been diagnosed with a rare form of cancer. The House Majority leader announced that he has been diagnosed with multiple myeloma, a form of blood cancer.

Steve Scalise, the second-ranking Republican in the US House of Representatives, has revealed that he has been diagnosed with a rare form of cancer. The House Majority leader announced that he has been diagnosed with multiple myeloma, a form of blood cancer. "I expect to work through this period and intend to return to Washington," said the Louisiana lawmaker who previously survived a mass shooting in 2017. Scalise's statement In a statement on Tuesday, Scalise said that he had sought medical attention after feeling unwell for a few days. "After a few days of not feeling like myself this past week, I had some blood work done". Also read | Air pollution: A silent threat deadlier than smoking and alcohol, reveals new study "The results uncovered some irregularities and after undergoing additional tests, I was diagnosed with Multiple Myeloma, a very treatable blood cancer," he added. Expressing gratitude for the early detection of the cancer, he said: "I am thankful for my excellent medical team, and with the help of God, support of my family, friends, colleagues, and constituents, I will tackle this with the same strength and energy as I have tackled past challenges." Who is Steve Scalise? The 57-year-old congressman was elected to the US Congress in 2008. Over the years, he steadily climbed the ranks of Republican leadership. Currently, he is serving as the right-hand man to House Speaker Kevin McCarthy, and plays a pivotal role in keeping the chamber's conservative majority in line. Also read | Drink and drive? Japanese police use unique approach to show dangers of drunk driving Notably, in 2017, Scalise was one of the five victims of a mass shooting during a congressional baseball practice. He was shot in the hip by a gunman who opened fire on the group, injuring five people. He underwent a months-long recovery and eventually returned to work. Colleagues and fellow politicians from the Republican Party offered messages of support to Scalise. Highlighting his remarkable recovery from the earlier shooting as a testament to his resilience, Senator Bill Cassidy of Louisiana said: "The same faith, family support, and internal strength that made Steve such an inspiration to others after he was shot, will bring him through this illness and once more inspire us all." Multiple myeloma Multiple myeloma is a relatively uncommon form of cancer in the United States. According to the American Cancer Society, approximately 35,730 new cases are expected to be diagnosed this year. This, as per a Forbes report citing the National Cancer Institute, represents merely two per cent of all cancer diagnoses in the country. The disease affects plasma cells, a type of white blood cell that helps our body's immune response.

Prominent Republican Steve Scalise diagnosed with rare form of blood cancer

In India, the latest figures show the trend of rising Cancer cases amongst the youth and it is now one of the major causes of death. Watch the video to know more.

Cancer: A leading cause of death worldwide | 2,100 people die of Cancer everyday in India | WION

Sharing food with your loved ones is often considered a way to deepen the love and care two people share. However, a study published in the journal Nature shows that a virus that is primarily spread through saliva can evolve into cancer. This virus can be transmitted when people kiss, or share drinks or food and affects more than 90 per cent of the world's population.

The virus is called Epstein-Barr virus or EBV and it is the cause of infectious mononucleosis or mono and other infections. As per an ANI news agency report, the virus frequently comes with no symptoms.&nbsp;

Most EBV infections are small and transient, however, in some cases, the virus can go dormant and reactivate later.&nbsp;

Long-lasting latent infections, i.e., infections by an organism that has for some time been inactive in the body, are&nbsp;associated with a number of cancers as well as several chronic inflammatory disorders.

Also read |&nbsp;<a href="https://www.wionews.com/technology/research-reveals-how-artificial-intelligence-can-help-look-for-alien-lifeforms-on-mars-and-other-planets-582992">Research reveals how Artificial Intelligence can help look for alien lifeforms on Mars and other planets</a>

Researchers at the University of California San Diego have discovered how the Epstein-Barr virus (EBV) can exploit genomic weaknesses to trigger cancer, while also decreasing the body's ability to suppress it.&nbsp;

They found that the virus induces cleavage of human chromosome 11, and triggers genomic instability, which can activate a leukaemia-causing oncogene and reduce the function of a major tumour suppressor.&nbsp;

Throughout every person's genome, there are fragile sites that are more prone to producing mutations, breaks, or gaps when replicating, some of which can cause cancer. The researchers found that EBNA1, a viral protein that remains in cells infected with EBV, binds to a fragile site on human chromosome 11, triggering chromosomal breakage.&nbsp;

Also read |&nbsp;<a href="https://www.wionews.com/science/traces-of-ancient-viruses-in-dna-of-humans-could-help-fight-cancer-study-582940">Traces of ancient viruses in DNA of humans could help fight cancer: Study</a>

Examining whole-genome sequencing data for 2,439 cancers across 38 tumour types from the Pan-Cancer Analysis of Whole Genomes project, they found that cancer tumours with detectable EBV had higher levels of chromosome 11 abnormalities. This was found to be true in cases including 100 per cent of head and neck cancer cases.&nbsp;

The findings could help identify at-risk individuals who are susceptible to developing latent infection-associated diseases, as the EBV virus is generally harmless for most people, said the study's first author Julia Li, PhD, a postdoctoral fellow in Cleveland's lab.

"For a ubiquitous virus that is harmless for the majority of the human population, identifying at-risk individuals susceptible to the development of latent infection-associated diseases is still an ongoing effort," she said.

(With inputs from agencies)

WATCH WION LIVE HERE

<iframe allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="350" loading="”lazy”" src="https://www.wionews.com/live-tv/embed?autoplay=1&amp;mute=1" width="100%"></iframe>

You can now write for wionews.com and be a part of the community. Share your stories and opinions with us <a href="https://www.wionews.com/content-contribution-registration-form">here</a>.

Sharing food with your loved ones is often considered a way to deepen the love and care two people share. However, a study published in the journal Nature shows that a virus that is primarily spread through saliva can evolve into cancer.

Sharing food with your loved ones is often considered a way to deepen the love and care two people share. However, a study published in the journal Nature shows that a virus that is primarily spread through saliva can evolve into cancer. This virus can be transmitted when people kiss, or share drinks or food and affects more than 90 per cent of the world's population. The virus is called Epstein-Barr virus or EBV and it is the cause of infectious mononucleosis or mono and other infections. As per an ANI news agency report, the virus frequently comes with no symptoms. Most EBV infections are small and transient, however, in some cases, the virus can go dormant and reactivate later. Long-lasting latent infections, i.e., infections by an organism that has for some time been inactive in the body, are associated with a number of cancers as well as several chronic inflammatory disorders. Also read | Research reveals how Artificial Intelligence can help look for alien lifeforms on Mars and other planets Researchers at the University of California San Diego have discovered how the Epstein-Barr virus (EBV) can exploit genomic weaknesses to trigger cancer, while also decreasing the body's ability to suppress it. They found that the virus induces cleavage of human chromosome 11, and triggers genomic instability, which can activate a leukaemia-causing oncogene and reduce the function of a major tumour suppressor. Throughout every person's genome, there are fragile sites that are more prone to producing mutations, breaks, or gaps when replicating, some of which can cause cancer. The researchers found that EBNA1, a viral protein that remains in cells infected with EBV, binds to a fragile site on human chromosome 11, triggering chromosomal breakage. Also read | Traces of ancient viruses in DNA of humans could help fight cancer: Study Examining whole-genome sequencing data for 2,439 cancers across 38 tumour types from the Pan-Cancer Analysis of Whole Genomes project, they found that cancer tumours with detectable EBV had higher levels of chromosome 11 abnormalities. This was found to be true in cases including 100 per cent of head and neck cancer cases. The findings could help identify at-risk individuals who are susceptible to developing latent infection-associated diseases, as the EBV virus is generally harmless for most people, said the study's first author Julia Li, PhD, a postdoctoral fellow in Cleveland's lab. "For a ubiquitous virus that is harmless for the majority of the human population, identifying at-risk individuals susceptible to the development of latent infection-associated diseases is still an ongoing effort," she said. (With inputs from agencies) WATCH WION LIVE HERE You can now write for wionews.com and be a part of the community. Share your stories and opinions with us here.

Study reveals how 'EBV' virus that spreads through saliva can lead to cancer

Over the past three decades (circa 1991-2023), the death rate from cancer in the US has declined by a startling 30 per cent. This amounts to about 3.8 million lives saved since 1991, according to research that was published in <a href="https://acsjournals.onlinelibrary.wiley.com/doi/full/10.3322/caac.21763">CA: A Cancer Journal for Clinicians</a>. Even better, the studies show that the death rate from cancer decreased from 2019 to 2020 by 1.5 per cent, which contrasts sharply with other major illnesses.

Researchers have shown that cancer is not only a major issue affecting worldwide health but also the second-worst killer in the US, after heart disease. COVID-19 takes the third spot.

<h2>Decline in cancer cases: What exactly happened?</h2>

Over the course of the three decades (circa 1991-2023), researchers estimated that 2.6 million deaths in men and 1.2 million in women from cancer were averted. Men saw a 2.6 per cent&nbsp;annual decline in lung cancer incidence from 2015 to 2019 compared to women's 1.1 per cent&nbsp;yearly decline.

Young women's (20–24-year-olds) risk of developing cervical cancer has dramatically decreased, falling by 11.4 per cent between 2012 and 2019 and by a staggering 65 per cent&nbsp;overall within the same time frame.

Also read |&nbsp;<a href="https://www.wionews.com/science/scientists-find-the-chocolaty-secret-to-chocolates-sweetness-552453">Scientists find the chocolaty secret to chocolate's sweetness</a>

Additionally, death rates for kidney cancer, melanoma, and leukemia decreased by two&nbsp;per cent&nbsp;year from 2016 to 2020.

<h2>How did the decline in cancer cases take place?</h2>

The study found that the death rate has dropped over the previous three decades as a result of a dip in smoking and advancements in cancer diagnosis and treatment.

The American Cancer Society's CEO, Karen Knudsen, told CNN that the drop in cancer mortality is "truly formidable."

“New revelations for prevention, for early detection, and for treatment have resulted in true, meaningful gains in many of the 200 diseases that we call cancer,” Knudsen added.

The first vaccination against the two strains of the human papillomavirus, according to researchers, is to credit for the drop in cervical cancer cases (which cause 70 per cent of such cancers).

The vaccination was originally permitted for use in females between the ages of 9 and 26 in 2006 by the US Food and Drug Administration, as per researchers.

“This totally follows the time when HPV vaccines were put into use,” Dr William Dahut, the society’s chief scientific officer, told&nbsp;CNN.

Also read |&nbsp;<a href="https://www.wionews.com/science/in-a-first-scientists-use-artificial-dna-to-kill-cancer-cells-heres-what-you-need-to-know-547276">Explained: In a first, scientists use artificial DNA to kill cancer cells: Here’s what you need to know</a>

The report&nbsp;also stated that the first group who received these strains' immunisations are currently in their 20s.

Conclusively,&nbsp;these findings point to sharp future declines in HPV malignancies, the majority of which affect women.

“There are other cancers that are HPV-related – whether that’s head and neck cancers or anal cancers – so there’s optimism this will have importance beyond this,” Dahut added.

<h2>Some cancers are on the rise</h2>

The latest research points out that occurrences of breast, uterine, and prostate cancer have been "of concern" and growing in the US, despite the fact that the overall cancer mortality rate has been steadily declining.

Cancer among adults under 50 may be on the rise globally. The research states that since the middle of the 2000s, the incidence rates of breast cancer in women have been rising by roughly 0.5 per cent&nbsp;per year.

Incidence of uterine corpus cancer has increased around one per cent year since the mid-2000s among women 50 and older and roughly two&nbsp;per cent annually since at least the mid-1990s among younger women.

After two decades of reduction, the incidence rate of prostate cancer increased by three per cent&nbsp;year from 2014 to 2019.

<h2>What did the White House say?</h2>

White House Cancer Moonshot Coordinator Dr&nbsp;Danielle Carnival stated in a statement issued on Thursday that the latest study "shows great progress."

President Biden renewed the White House's "Cancer Moonshot" project last year, pledging the country to aim toward cutting the death rate from cancer by at least 50 per cent over the following 25 years.

“The report showing the US&nbsp;has cut cancer deaths by one-third over the last 30 years is great progress, which we’ve achieved through driving smoking rates down, improving early detection, and delivering better treatments for many cancers. It means millions of American families have been spared the immeasurable loss of a loved one,” Carnival said in a&nbsp;statement quoted by CNN.&nbsp;

“The report also underscores that there’s more work to do to save more lives,” she said. “President Biden’s vision for ending cancer as we know it is building on the progress we’ve made with an all-hands-on-deck effort to develop new ways to prevent, detect, and treat cancer – and ensure that the tools we have and those we develop along the way reach all Americans.”

(With inputs from agencies)

WATCH WION LIVE HERE:

<iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/live-tv/embed" style="width:100%;max-width:560px;" width="560"></iframe>

Over the past three decades (circa 1991-2023), the death rate from cancer in the US has declined by a startling 30 per cent. This amounts to about 3.8 million lives saved since 1991, according to research that was published in CA: A Cancer Journal for Clinicians.

Over the past three decades (circa 1991-2023), the death rate from cancer in the US has declined by a startling 30 per cent. This amounts to about 3.8 million lives saved since 1991, according to research that was published in CA: A Cancer Journal for Clinicians. Even better, the studies show that the death rate from cancer decreased from 2019 to 2020 by 1.5 per cent, which contrasts sharply with other major illnesses. Researchers have shown that cancer is not only a major issue affecting worldwide health but also the second-worst killer in the US, after heart disease. COVID-19 takes the third spot. Decline in cancer cases: What exactly happened? Over the course of the three decades (circa 1991-2023), researchers estimated that 2.6 million deaths in men and 1.2 million in women from cancer were averted. Men saw a 2.6 per cent annual decline in lung cancer incidence from 2015 to 2019 compared to women's 1.1 per cent yearly decline. Young women's (20–24-year-olds) risk of developing cervical cancer has dramatically decreased, falling by 11.4 per cent between 2012 and 2019 and by a staggering 65 per cent overall within the same time frame. Also read | Scientists find the chocolaty secret to chocolate's sweetness Additionally, death rates for kidney cancer, melanoma, and leukemia decreased by two per cent year from 2016 to 2020. How did the decline in cancer cases take place? The study found that the death rate has dropped over the previous three decades as a result of a dip in smoking and advancements in cancer diagnosis and treatment. The American Cancer Society's CEO, Karen Knudsen, told CNN that the drop in cancer mortality is "truly formidable." “New revelations for prevention, for early detection, and for treatment have resulted in true, meaningful gains in many of the 200 diseases that we call cancer,” Knudsen added. The first vaccination against the two strains of the human papillomavirus, according to researchers, is to credit for the drop in cervical cancer cases (which cause 70 per cent of such cancers). The vaccination was originally permitted for use in females between the ages of 9 and 26 in 2006 by the US Food and Drug Administration, as per researchers. “This totally follows the time when HPV vaccines were put into use,” Dr William Dahut, the society’s chief scientific officer, told CNN. Also read | Explained: In a first, scientists use artificial DNA to kill cancer cells: Here’s what you need to know The report also stated that the first group who received these strains' immunisations are currently in their 20s. Conclusively, these findings point to sharp future declines in HPV malignancies, the majority of which affect women. “There are other cancers that are HPV-related – whether that’s head and neck cancers or anal cancers – so there’s optimism this will have importance beyond this,” Dahut added. Some cancers are on the rise The latest research points out that occurrences of breast, uterine, and prostate cancer have been "of concern" and growing in the US, despite the fact that the overall cancer mortality rate has been steadily declining. Cancer among adults under 50 may be on the rise globally. The research states that since the middle of the 2000s, the incidence rates of breast cancer in women have been rising by roughly 0.5 per cent per year. Incidence of uterine corpus cancer has increased around one per cent year since the mid-2000s among women 50 and older and roughly two per cent annually since at least the mid-1990s among younger women. After two decades of reduction, the incidence rate of prostate cancer increased by three per cent year from 2014 to 2019. What did the White House say? White House Cancer Moonshot Coordinator Dr Danielle Carnival stated in a statement issued on Thursday that the latest study "shows great progress." President Biden renewed the White House's "Cancer Moonshot" project last year, pledging the country to aim toward cutting the death rate from cancer by at least 50 per cent over the following 25 years. “The report showing the US has cut cancer deaths by one-third over the last 30 years is great progress, which we’ve achieved through driving smoking rates down, improving early detection, and delivering better treatments for many cancers. It means millions of American families have been spared the immeasurable loss of a loved one,” Carnival said in a statement quoted by CNN. “The report also underscores that there’s more work to do to save more lives,” she said. “President Biden’s vision for ending cancer as we know it is building on the progress we’ve made with an all-hands-on-deck effort to develop new ways to prevent, detect, and treat cancer – and ensure that the tools we have and those we develop along the way reach all Americans.” (With inputs from agencies) WATCH WION LIVE HERE:

Explained: How did US cancer rates drop by 33% since 1991?

If you are a woman under the age of 35, you might want to consult your doctors and make sure you get your medical check-ups on time because a study has warned that women in this age are more vulnerable to spreading of breast cancer.<o:p></o:p>

According to a group of scientists, women diagnosed with breast cancer under the age of 35 have a higher risk of the disease spreading.<o:p></o:p>

Experts carried out a meta analysis of more than 400 studies and found that the risk of breast cancer spreading to other body parts range from six per cent to 22 per cent.

<o:p>Also read |&nbsp;<a href="https://www.wionews.com/science/this-is-a-breakthrough-researchers-identify-potential-new-drug-treatment-for-covid-19-425169">'This is a breakthrough': Researchers identify potential new drug treatment for COVID-19</a></o:p>

Presented at the sixth International Consensus Conference for Advanced Breast Cancer, the findings of the study suggest that women under the age of 35 and those already suffering from the deadly disease are more at risk. This study has helped scientists figure out who is most at risk.<o:p></o:p>

Experts studied data of tens of thousands of women from North and South America, South Africa, Asia and Oceania. The analysis was conducted after combining more than 400 studies.<o:p></o:p>

In the UK, alone, nearly a thousand people lose their life to incurable secondary breast cancer in a month. "We desperately need to learn more about this devastating disease so that we can find new ways to improve treatment, care and support for people living with it, and for those living in fear of a diagnosis," Kotryna Temcinaite, senior research communications manager at the charity Breast Cancer Now said.

Also read |&nbsp;<a href="https://www.wionews.com/science/homo-bodoensis-its-official-we-have-a-new-ancestor-425007" hreflang="en">Homo bodoensis: It's official, we have a new ancestor</a><o:p></o:p>

As per the analysis, people who have been diagnosed with primary breast cancer before the age of 35 have a higher chance of developing secondary breast cancer. It is also possible that women can develop secondary breast cancer years after their initial diagnosis. <o:p></o:p>

It has also been observed that the size of the tumour, type of breast cancer and the length of time since the primary diagnosis can also have major impact on the scale of risk.<o:p></o:p>

"This may be because younger women have a more aggressive form of breast cancer or because they are being diagnosed at a later stage," said the presenter of the study, Dr Eileen Morgan, of the International Agency for Research on Cancer (IARC).<o:p></o:p>

"Breast cancer is the most common form of cancer in the world,"&nbsp;she said. "Most women are diagnosed when their cancer is confined to the breast or has only spread to nearby tissue. But in some women, the cancer will grow and spread to other parts of the body or come back in a different part of the body several years after the end of their initial treatment.<o:p></o:p>

"At this point the cancer becomes much harder to treat and the risk of dying is higher. However, we don't really know how many people develop metastatic breast cancer because cancer registries have not been routinely collecting this data."<o:p></o:p>

If you are a woman under the age of 35, you might want to consult your doctors and make sure you get your medical check-ups on time because a study has warned that women in this age are more vulnerable to spreading of breast cancer.

If you are a woman under the age of 35, you might want to consult your doctors and make sure you get your medical check-ups on time because a study has warned that women in this age are more vulnerable to spreading of breast cancer. According to a group of scientists, women diagnosed with breast cancer under the age of 35 have a higher risk of the disease spreading. Experts carried out a meta analysis of more than 400 studies and found that the risk of breast cancer spreading to other body parts range from six per cent to 22 per cent. Also read | 'This is a breakthrough': Researchers identify potential new drug treatment for COVID-19 Presented at the sixth International Consensus Conference for Advanced Breast Cancer, the findings of the study suggest that women under the age of 35 and those already suffering from the deadly disease are more at risk. This study has helped scientists figure out who is most at risk. Experts studied data of tens of thousands of women from North and South America, South Africa, Asia and Oceania. The analysis was conducted after combining more than 400 studies. In the UK, alone, nearly a thousand people lose their life to incurable secondary breast cancer in a month. "We desperately need to learn more about this devastating disease so that we can find new ways to improve treatment, care and support for people living with it, and for those living in fear of a diagnosis," Kotryna Temcinaite, senior research communications manager at the charity Breast Cancer Now said. Also read | Homo bodoensis: It's official, we have a new ancestor As per the analysis, people who have been diagnosed with primary breast cancer before the age of 35 have a higher chance of developing secondary breast cancer. It is also possible that women can develop secondary breast cancer years after their initial diagnosis. It has also been observed that the size of the tumour, type of breast cancer and the length of time since the primary diagnosis can also have major impact on the scale of risk. "This may be because younger women have a more aggressive form of breast cancer or because they are being diagnosed at a later stage," said the presenter of the study, Dr Eileen Morgan, of the International Agency for Research on Cancer (IARC). "Breast cancer is the most common form of cancer in the world," she said. "Most women are diagnosed when their cancer is confined to the breast or has only spread to nearby tissue. But in some women, the cancer will grow and spread to other parts of the body or come back in a different part of the body several years after the end of their initial treatment. "At this point the cancer becomes much harder to treat and the risk of dying is higher. However, we don't really know how many people develop metastatic breast cancer because cancer registries have not been routinely collecting this data."

Women under age of 35 more vulnerable to breast cancer spreading: Study

Authorities in Hong Kong have found eating biscuits can cause cancer after the city's consumer watchdog studied 60 different biscuits.

The biscuits were pre-packed and had cancer-causing&nbsp;substances called glycidol and acrylamide both chemicals are carcinogens and have shown&nbsp;to induce cancer.

Although biscuit manufacturers can use glycidol and acrylamide but there are limits to how much these chemicals can be used.&nbsp;The European Union benchmark for biscuits says acrylamide should be limited to 350 grams for a kg of biscuit which is considered to be a safe limit.

However, regulators found that at least four biscuit brands exceeded the limit. Muji's sandwich cracker had 620 grams of acrylamide which is almost double the safe limit. Among the carcinogenic biscuits was also Oreo, Marie and Pretz wafers.&nbsp;

The study also found 56 of the 60 sampled biscuits had what's called 3 MCPD&nbsp;which is an organic chemical compound. It is known to affect kidneys and male reproductive organs. It is recommended&nbsp;that an adult who weighs about 60 kgs should not consume more than 120 grams of this chemical in a day but some biscuits had 2,000 grams of 3 MCPD&nbsp;for every kg.

At least 33 samples of biscuits were also found to be high fat and 27 samples were high sugar with&nbsp;13 with high sodium. Forty per cent of the biscuits had misleading nutrition labels.

While the study sampled biscuits found in Hong Kong, its result applies to markets outside too. Biscuits have a high quantity of sugar and&nbsp;fat.

In 2017, India's consumer education and research centre had found cream biscuits manufactured in the country mostly exceeded the prescribed sugar and fat content which is 25 to 30 gram per kg and 20 grams per 100 kg respectively.

Biscuits also have a high quantity of salt. An average sweet biscuit contains 0.4 grams of salt per 25-gram bag. The fact is too much of salt can put a person at risk of a heart attack. Packed biscuits also have preservatives including colouring agents.

Biscuits may be the most humble snack but it is not necessarily the most healthy snack as some packets promise to be light, some promise they are whole wheat or oatmeal, fibre-rich or sugar-free but these terms are often just marketing gimmicks.

Sugar-free biscuits simply replace sugar with artificial sweeteners. Oatmeal biscuits may contain just about 5 to 10 per cent of oats.

A study was conducted in Sweden among 60,000 women over 10 years found women who ate biscuits more than 2 to 3 times a week were 33 per cent more likely to develop womb cancer. Women who ate biscuits more than three times a week were 42 per cent more likely to develop a tumour.

Authorities in Hong Kong have found eating biscuits can cause cancer after the city's consumer watchdog studied 60 different biscuits. The biscuits were pre-packed and had cancer-causing substances called glycidol and acrylamide both chemicals are carcinogens and have shown to induce cancer.

Authorities in Hong Kong have found eating biscuits can cause cancer after the city's consumer watchdog studied 60 different biscuits. The biscuits were pre-packed and had cancer-causing substances called glycidol and acrylamide both chemicals are carcinogens and have shown to induce cancer. Although biscuit manufacturers can use glycidol and acrylamide but there are limits to how much these chemicals can be used. The European Union benchmark for biscuits says acrylamide should be limited to 350 grams for a kg of biscuit which is considered to be a safe limit. However, regulators found that at least four biscuit brands exceeded the limit. Muji's sandwich cracker had 620 grams of acrylamide which is almost double the safe limit. Among the carcinogenic biscuits was also Oreo, Marie and Pretz wafers. The study also found 56 of the 60 sampled biscuits had what's called 3 MCPD which is an organic chemical compound. It is known to affect kidneys and male reproductive organs. It is recommended that an adult who weighs about 60 kgs should not consume more than 120 grams of this chemical in a day but some biscuits had 2,000 grams of 3 MCPD for every kg. At least 33 samples of biscuits were also found to be high fat and 27 samples were high sugar with 13 with high sodium. Forty per cent of the biscuits had misleading nutrition labels. While the study sampled biscuits found in Hong Kong, its result applies to markets outside too. Biscuits have a high quantity of sugar and fat. In 2017, India's consumer education and research centre had found cream biscuits manufactured in the country mostly exceeded the prescribed sugar and fat content which is 25 to 30 gram per kg and 20 grams per 100 kg respectively. Biscuits also have a high quantity of salt. An average sweet biscuit contains 0.4 grams of salt per 25-gram bag. The fact is too much of salt can put a person at risk of a heart attack. Packed biscuits also have preservatives including colouring agents. Biscuits may be the most humble snack but it is not necessarily the most healthy snack as some packets promise to be light, some promise they are whole wheat or oatmeal, fibre-rich or sugar-free but these terms are often just marketing gimmicks. Sugar-free biscuits simply replace sugar with artificial sweeteners. Oatmeal biscuits may contain just about 5 to 10 per cent of oats. A study was conducted in Sweden among 60,000 women over 10 years found women who ate biscuits more than 2 to 3 times a week were 33 per cent more likely to develop womb cancer. Women who ate biscuits more than three times a week were 42 per cent more likely to develop a tumour.

Eating too many biscuits may cause cancer, study finds

According to the Indian Council of Medical Research (ICMR), children&nbsp;below 14 years accounted for 7.9 per cent of all cancer cases between 2012 to 2019.

The report titled "Clinicopathological Profile of Cancers in India" found the disease was&nbsp;prevalent&nbsp;among 52 per cent in men and 47.6 among women.

<a href="https://www.wionews.com/science/this-single-blood-test-can-detect-50-types-of-cancer-before-symptoms-emerge-393864">Also Read:&nbsp;This single blood test can detect 50 types of cancer before symptoms emerge</a>

The research analysed data from 96 hospitals and found that those between 45 to 64 years were diagnosed with cancer the most with prostate cancer being highest among those over 65.

<a href="https://www.wionews.com/world/ai-used-by-scientists-to-discover-a-treatment-for-childhood-cancer-415247">Also Read:&nbsp;AI used by scientists to discover a treatment for childhood cancer</a>

The study said lung and gall bladder cancer including prostate cancer was widely prevalent among both men and women.

The report stated that chemotherapy was the most prevalent form of treatment regardless of the extent of the disease as it found head and neck region was the worst affected part of the human body.

<a href="https://www.wionews.com/science/mothers-obesity-linked-with-adulthood-cancer-in-children-study-408134">Also Read:&nbsp;Mother's obesity linked with adulthood cancer in children</a>

Gynaecologic and breast cancer was the most prevalent among women, the study said. India reported 13,32,207 cases of cancer in the seven-year period between 2012 to 2019.

Lymphoma is reportedly the most common form of childhood cancer among boys accounting for 16.4 per cent of cases while girls suffered from the malignant bone tumour the most which accounted for 8.9 per cases.&nbsp;

However, Leukaemia affected nearly half of the children among both boys and girls in the age group of 14 and under accounting for 44 per cent in girls and 46 per cent among boys.

(With inputs from Agencies)

 
&nbsp;

According to the Indian Council of Medical Research (ICMR), children below 14 years accounted for 7.9 per cent of all cancer cases between 2012 to 2019. The report titled "Clinicopathological Profile of Cancers in India" found the disease was prevalent among 52 per cent in men and 47.

According to the Indian Council of Medical Research (ICMR), children below 14 years accounted for 7.9 per cent of all cancer cases between 2012 to 2019. The report titled "Clinicopathological Profile of Cancers in India" found the disease was prevalent among 52 per cent in men and 47.6 among women. Also Read: This single blood test can detect 50 types of cancer before symptoms emerge The research analysed data from 96 hospitals and found that those between 45 to 64 years were diagnosed with cancer the most with prostate cancer being highest among those over 65. Also Read: AI used by scientists to discover a treatment for childhood cancer The study said lung and gall bladder cancer including prostate cancer was widely prevalent among both men and women. The report stated that chemotherapy was the most prevalent form of treatment regardless of the extent of the disease as it found head and neck region was the worst affected part of the human body. Also Read: Mother's obesity linked with adulthood cancer in children Gynaecologic and breast cancer was the most prevalent among women, the study said. India reported 13,32,207 cases of cancer in the seven-year period between 2012 to 2019. Lymphoma is reportedly the most common form of childhood cancer among boys accounting for 16.4 per cent of cases while girls suffered from the malignant bone tumour the most which accounted for 8.9 per cases. However, Leukaemia affected nearly half of the children among both boys and girls in the age group of 14 and under accounting for 44 per cent in girls and 46 per cent among boys. (With inputs from Agencies)

7.9% of all cancer cases were found among children: ICMR study

Cancer is an unnatural growth of cells that wrecks the healthy environment of the body. The complications associated with it is not because of the disease, but due to the delayed diagnosis as the symptoms are mostly unclear at times. 
 
India has recorded a 333 per cent increase in online consultations with oncologists between January and December 2020, as per Practo`s latest insights report. Of the total online consultations, 40 per cent came from non-metro cities while 60 per cent from metro cities. Non-metros recorded a steep 932 per cent increase in the number of online consultations, while the metro cities grew by 410 per cent. 
 
The findings indicated increased awareness about the disease and improved access to cancer specialists online, especially in non-metro cities - from 5 per cent in 2018 and 20 per cent in 2019 to 40 per cent in 2020. 
 
Meanwhile, a new observation was made in 2020 - the top searched queries were different in different parts of the country. People in non-metro cities enquired more about types of cancer such as bladder, thyroid, ovaries, and anal. In metro cities, on the other hand, the majority of queries revolved around more common types of cancer (like blood, breast, cervical, and oral). 
 
On World Cancer Day marked across the globe on February 4 every year, Oncologist at Practo shares a list of commonly ignored symptoms, which could be warning signs of cancer. Cancers are painless when they start and so they get ignored by the patient and doctors alike. 
 
Anaemia: Tiredness in cancer is usually due anaemia (lack of blood) and deficiency of nutrition. The cancer drains most of nutrients from the body in its race to grow rapidly. Also there is bleeding from cancer tissue that makes one anaemic. 
 
Blood while passing stool: Very often, this is due to piles or similar causes. However, colon cancer and rectum cancer can also cause this. If a person happens to find blood in stool, it is wise to do colonoscopy to look inside of the colon. Cancer of colon can cause change in bowel habit (like alternating constipation and diarrhoea) 
 
Blood in urine: This always requires further tests. Cancer of the kidney or urinary bladder or prostate can result in blood in urine. The worst part is this bleeding can be irregular. This infrequency makes patients ignore this symptom. Even one episode of blood in urine needs through examination. 
 
Bleeding in between periods (women): Any bleeding that does not follow the usual pattern of menstrual period is a warning sign. Cancer of the uterus or cervix can cause these kinds of symptoms. Patients with cervical cancer also bleed after sexual intercourse. 
 
A patch or wound inside mouth: Oral or mouth cancers are common in India. These cancers start as a patch or wound and progress over months. If diagnosed early they can be treated effectively. 
 
Lump or swelling: Cancers of breast and limb begin as painless lumps or swellings and progress over months. Any newly appearing lumps or swellings should be thoroughly examined. 
 
Loss of weight without trying: A sudden weight loss when you are not dieting needs investigations. As cancer consumes most of the nutrition that you take, you tend to lose it. 
 
Loss of appetite and bloating food: This could be because of obstruction to bowel or because of a cancer secreting its toxic substances. Thorough examination is needed to reach a diagnosis. 
 
Lymph node enlargement: Lymph nodes are present everywhere in the body and function as filters. Most of the time they enlarge due to infections. The cancer cells also get filtered in these nodes and are trapped. They grow in these nodes and the nodes enlarge because of this growth. 
 
Trouble swallowing or vomiting after taking food are both warning signs of a cancer in the digestive tract. These need to be evaluated with endoscopic tests to identify the cause. Some patients have only persistent heartburns which are misdiagnosed as gastritis and treated only for months before correct diagnosis reveals itself. 
 
Pain is the last feature of cancer. Do not wait for it. 
 
 
&nbsp;

Cancer is an unnatural growth of cells that wrecks the healthy environment of the body. The complications associated with it is not because of the disease, but due to the delayed diagnosis as the symptoms are mostly unclear at times.

Cancer is an unnatural growth of cells that wrecks the healthy environment of the body. The complications associated with it is not because of the disease, but due to the delayed diagnosis as the symptoms are mostly unclear at times. India has recorded a 333 per cent increase in online consultations with oncologists between January and December 2020, as per Practo`s latest insights report. Of the total online consultations, 40 per cent came from non-metro cities while 60 per cent from metro cities. Non-metros recorded a steep 932 per cent increase in the number of online consultations, while the metro cities grew by 410 per cent. The findings indicated increased awareness about the disease and improved access to cancer specialists online, especially in non-metro cities - from 5 per cent in 2018 and 20 per cent in 2019 to 40 per cent in 2020. Meanwhile, a new observation was made in 2020 - the top searched queries were different in different parts of the country. People in non-metro cities enquired more about types of cancer such as bladder, thyroid, ovaries, and anal. In metro cities, on the other hand, the majority of queries revolved around more common types of cancer (like blood, breast, cervical, and oral). On World Cancer Day marked across the globe on February 4 every year, Oncologist at Practo shares a list of commonly ignored symptoms, which could be warning signs of cancer. Cancers are painless when they start and so they get ignored by the patient and doctors alike. Anaemia: Tiredness in cancer is usually due anaemia (lack of blood) and deficiency of nutrition. The cancer drains most of nutrients from the body in its race to grow rapidly. Also there is bleeding from cancer tissue that makes one anaemic. Blood while passing stool: Very often, this is due to piles or similar causes. However, colon cancer and rectum cancer can also cause this. If a person happens to find blood in stool, it is wise to do colonoscopy to look inside of the colon. Cancer of colon can cause change in bowel habit (like alternating constipation and diarrhoea) Blood in urine: This always requires further tests. Cancer of the kidney or urinary bladder or prostate can result in blood in urine. The worst part is this bleeding can be irregular. This infrequency makes patients ignore this symptom. Even one episode of blood in urine needs through examination. Bleeding in between periods (women): Any bleeding that does not follow the usual pattern of menstrual period is a warning sign. Cancer of the uterus or cervix can cause these kinds of symptoms. Patients with cervical cancer also bleed after sexual intercourse. A patch or wound inside mouth: Oral or mouth cancers are common in India. These cancers start as a patch or wound and progress over months. If diagnosed early they can be treated effectively. Lump or swelling: Cancers of breast and limb begin as painless lumps or swellings and progress over months. Any newly appearing lumps or swellings should be thoroughly examined. Loss of weight without trying: A sudden weight loss when you are not dieting needs investigations. As cancer consumes most of the nutrition that you take, you tend to lose it. Loss of appetite and bloating food: This could be because of obstruction to bowel or because of a cancer secreting its toxic substances. Thorough examination is needed to reach a diagnosis. Lymph node enlargement: Lymph nodes are present everywhere in the body and function as filters. Most of the time they enlarge due to infections. The cancer cells also get filtered in these nodes and are trapped. They grow in these nodes and the nodes enlarge because of this growth. Trouble swallowing or vomiting after taking food are both warning signs of a cancer in the digestive tract. These need to be evaluated with endoscopic tests to identify the cause. Some patients have only persistent heartburns which are misdiagnosed as gastritis and treated only for months before correct diagnosis reveals itself. Pain is the last feature of cancer. Do not wait for it.

World Cancer Day: 10 symptoms people should not ignore

cancer-cases

Cancer Cases, News on Cancer Cases, stories on Cancer Cases, articles on Cancer Cases, Cancer Cases stories at Wion, Cancer Cases news, Cancer Cases latest news